Research ArticleClinical Sciences
Reversal of Brain Metabolic Abnormalities Following Treatment of AIDS Dementia Complex with 3′-azido-2′,3′-Dideoxythymidine (AZT, Zidovudine): A PET-FDG Study
Arturo Brunetti, Gary Berg, Giovanni Di Chiro, Robert M. Cohen, Robert Yarchoan, Philip A. Pizzo, Samuel Broder, Janie Eddy, Michael J. Fulham, Ronald D. Finn and Steven M. Larson
Journal of Nuclear Medicine May 1989, 30 (5) 581-590;
Arturo Brunetti
Gary Berg
Giovanni Di Chiro
Robert M. Cohen
Robert Yarchoan
Philip A. Pizzo
Samuel Broder
Janie Eddy
Michael J. Fulham
Ronald D. Finn


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Reversal of Brain Metabolic Abnormalities Following Treatment of AIDS Dementia Complex with 3′-azido-2′,3′-Dideoxythymidine (AZT, Zidovudine): A PET-FDG Study
Arturo Brunetti, Gary Berg, Giovanni Di Chiro, Robert M. Cohen, Robert Yarchoan, Philip A. Pizzo, Samuel Broder, Janie Eddy, Michael J. Fulham, Ronald D. Finn, Steven M. Larson
Journal of Nuclear Medicine May 1989, 30 (5) 581-590;
Reversal of Brain Metabolic Abnormalities Following Treatment of AIDS Dementia Complex with 3′-azido-2′,3′-Dideoxythymidine (AZT, Zidovudine): A PET-FDG Study
Arturo Brunetti, Gary Berg, Giovanni Di Chiro, Robert M. Cohen, Robert Yarchoan, Philip A. Pizzo, Samuel Broder, Janie Eddy, Michael J. Fulham, Ronald D. Finn, Steven M. Larson
Journal of Nuclear Medicine May 1989, 30 (5) 581-590;
Jump to section
Related Articles
- No related articles found.